Strategic actions supporting large-scale clinical trials 2016

The purpose of this call for proposals is to support strategic clinical research activities which are part of a large-scale clinical trial that has the potential to achieve rapid advances in the clinical development of new or improved medical interventions against poverty-related infectious diseases.

Towards an adopted, safe, effective combination treatment for African visceral leishmaniasis (Kala Azar) and improved diagnostic tools

Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland, with partners from Ethiopia, Kenya, The Netherlands, Spain, Sudan, Switzerland, Uganda, and the United Kingdom
Grant agreement: RIA2016S-1635
Project coordinator:
Dr Jorge Alvar (DNDi, Geneva, Switzerland)
Starting date:
1 December 2017
Duration: 36 months
Total project value: EUR 11,588,438
EDCTP grant amount: EUR 5,560,748
Co-funding from: Amsterdam Medical Centre (AMC) and Nederlands Kanker Instituut (NKI) (both in The Netherlands), Instituto de Salud Carlos III (ISCIII; Spain) DNDi and FIND (both in Switzerland), Liverpool School of Hygiene and Tropical Medicine (LSHTM; United Kingdom).

Tuberculosis reduction through expanded antiretroviral treatment and screening for active TB

London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom, with partners from France, Germany, Netherlands, South Africa, United Kingdom, and Zambia
Grant agreement: RIA2016S-1632
Project coordinator:
 Prof. Helen Ayles (LSHTM, London, United Kingdom)
Starting date:
1 November 2017
Duration: 48 months
Total project value: EUR to be added
EDCTP grant amount: EUR 12,902,402
Co-funding from: to be added.